RFK Jr.’s FDA Expected to Lift Restrictions on Risky, Unproven Peptides

RFK Jr.’s FDA expected to lift restrictions on risky, unproven peptides

The FDA is reportedly planning to allow production of 14 previously banned peptides.

Report: FDA Set to Unban RFK Jr.'s Favorite Peptides

More than a dozen peptides are expected to be removed from a list that bans compounding pharmacies from producing them.

Heeding Kennedy's Wishes, FDA Is Expected to Lift Restriction on Peptides

The Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, according to a senior administration official.

The FDA is expected to lift restrictions on certain peptides, the NYT reports

Peptides — a class of understudied and often injectable supplements — have boomed in popularity, with search interest for “peptides” surpassing “ozempic” this month.

FDA to Lift Peptide Restrictions: A New Era for Biopharma

FDA to Lift Peptide Restrictions: A New Era for Biopharma The U.S. Food and Drug Administration is reportedly preparing to lift existing restrictions on peptides, according to a report by the New York Times.This regulatory change is expected to catalyze advancements in the biopharmaceutical sector, opening new avenues for research and drug development.The anticipated relaxation could foster innovation, leading to potential breakthroughs and expa…

The wellness world is eager for RFK Jr.'s promised move on peptides

A month ago, Health Secretary Kennedy said his agency would soon give compounding pharmacies the greenlight to make the products, which have exploded in popularity despite a lack of data.